跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OPENVAS PLUS 40 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OPENVAS PLUS 40 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
OPENVAS PLUS 40 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Daiichi Sankyo Italia S.P.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 26, 2024
Approval ID
e06fcb86e76e7db0
Company
Daiichi Sankyo Italia S.P.A.
Type
Standard
Approval Details
Approval Id
e06fcb86e76e7db0
Drug Cima Aemps Name
OPENVAS PLUS 40 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
037110246IP1
Holder Company Name
Daiichi Sankyo Italia S.P.A.
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2024-09-26
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg/12,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Daiichi Sankyo Italia S.P.A.
Active Ingredients
OLMESARTAN MEDOXOMILO
40 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 26, 2024
Approval ID
e06fcb86e76e7db0
Type
Standard
Back to CIMA-AEMPS Approvals